Australian Clinical Labs (ASX:ACL) upgrades guidance as Omicron testing surges
Lachlan Buur-Jensen
December 21, 2021
The Australian Clinical Labs Ltd (ASX: ACL) share price is
Australian Clinical Labs Limited (ASX:ACL) is an Australian private provider of pathology services. The company has 86 accredited laboratories performing a diverse range of pathology tests each year for a range of clients including doctors, specialists, patients, hospitals and corporate clients. ACL is one of the largest private hospital pathology businesses nationally.
The Australian Clinical Labs Ltd (ASX: ACL) share price is
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.